18638 Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices 

RECORD SOURCE CATEGORIES: 

Records are obtained directly from the 

subject individuals, or from the 

following sources: educational 

institutions; internship and/or residency 

training programs; employers; NHSCapproved service sites; critical shortage 

facilities; schools of nursing; lending 

institutions and loan servicing agencies; 

health professional associations; 

National Practitioner Data Bank; System 

for Awards Management (formerly 

Excluded Parties List System); HHS 

Office of Inspector General Web site 

listing of individuals excluded from 

Medicare, Medicaid, and all other 

federal health care programs; HHS 

database of Health Professional Shortage 

Areas; HHS grantees and contractors/

subcontractors; consumer reporting 

agencies/credit bureaus; other federal 

agencies, including but not limited to 

the Department of the Treasury, IRS, 

and the U.S. Postal Service; state health 

professions licensing boards and/or the 

Federation of State Medical Boards or a 

similar non-government entity; and 

third parties who provide references or 

other information concerning the 

subject individual. 

SYSTEM EXEMPTED FROM CERTAIN PROVISIONS

OF THE ACT: 

None. 

[FR Doc. 2015–07899 Filed 4–6–15; 8:45 am] 

BILLING CODE CODE 4160–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

has taken final action in the following 

case: 

Teresita L. Briones, Ph.D., Wayne 

State University: Based on the report of 

an inquiry conducted by Wayne State 

University (WSU) and additional 

analysis conducted by ORI in its 

oversight review, ORI found that Dr. 

Teresita L. Briones, former Associate 

Professor, College of Nursing, WSU, 

engaged in research misconduct in 

research supported by National Institute 

of Nursing Research (NINR), National 

Institutes of Health (NIH), grants P30 

NR009014, R01 NR005260, and R01 

NR007666. 

ORI found that Respondent 

intentionally, knowingly, and recklessly 

engaged in research misconduct by 

falsifying and/or fabricating data that 

were included in five (5) publications 

and three (3) grant applications 

submitted to NINR, NIH: 

Behavioural Brain Research 279:112–22, 

2015 Feb 15 (hereafter referred to as 

‘‘BBR 2015’’) 

• Journal of Neuroinflammation 11:13, 

2014 Jan 22 (hereafter referred to as 

‘‘JNI 2014’’) 

• Journal of Neurotrauma 26(4):613–25, 

2009 Apr (hereafter referred to as 

‘‘JNT 2009’’) 

• Journal of Neurotrauma 28(12):2485– 

92, 2011 Dec (hereafter referred to as 

‘‘JNT 2011’’) 

• Neuroscience 262:143–55, 2014 Mar 

14 (hereafter referred to as ‘‘NS 2014’’) 

• R01 NR011167–01 

• R01 NR011167–01A1 

• R01 NR 011167–01A2 

ORI found that Respondent falsified 

and/or fabricated data by falsely 

reporting the results of Western blot 

experiments that examined 

neuroinflammation, amyloidogenesis, 

and/or cognitive impairment in a rat 

model of cerebral ischemia. Specifically, 

Respondent duplicated, reused, and 

falsely relabeled Western blot gel images 

and claimed they represented different 

experiments in: 

• BBR 2015, Figures 2E and 5D 

• JNI 2014, Figures 2A and 2C 

• JNT 2009, Figures 2B and 5 

• JNT 2011, Figure 2 

• NS 2014, Figure 4 

• R01 NR011167–01, Figures 5 and 6 

• R01 NR011167–01A1, Figures 4A and 

4B 

• R01 NR011167–01A2, Figures 4A and 

4B 

As a result of this Agreement, 

Respondent will request that the 

following publications be retracted: BBR 

2015, JNI 2014, JNT 2009, JNT 2011, and 

NS 2014. 

Dr. Briones has entered into a 

Voluntary Exclusion Agreement 

(Agreement) and has voluntarily agreed 

for a period of three (3) years, beginning 

on March 12, 2015: 

(1) to exclude herself from any 

contracting or subcontracting with any 

agency of the United States Government 

and from eligibility for or involvement 

in nonprocurement programs of the 

United States Government referred to as 

‘‘covered transactions’’ pursuant to 

HHS’ Implementation (2 CFR part 376 et 

seq) of OMB Guidelines to Agencies on 

Governmentwide Debarment and 

Suspension, 2 CFR part 180 (collectively 

the ‘‘Debarment Regulations’’); 

(2) to exclude herself voluntarily from 

serving in any advisory capacity to the 

U.S. Public Health Service (PHS) 

including, but not limited to, service on 

any PHS advisory committee, board, 

and/or peer review committee, or as a 

consultant; and 

(3) to request that the following 

publications be retracted: BBR 2015, JNI 

2014, JNT 2009, JNT 2011, and NS 2014. 

FOR FURTHER INFORMATION CONTACT: 

Acting Director, Office of Research 

Integrity, 1101 Wootton Parkway, Suite 

750, Rockville, MD 20852, (240) 453– 

8200. 

Donald Wright, 

Acting Director, Office of Research Integrity. 

[FR Doc. 2015–07896 Filed 4–6–15; 8:45 am] 

BILLING CODE CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

has taken final action in the following 

case: 

Ryousuke Fujita, Ph.D., Columbia 

University: Based on the report of an 

investigation conducted by Columbia 

University (CU) and additional analysis 

conducted by ORI in its oversight 

review, ORI found that Dr. Ryousuke 

Fujita, former Postdoctoral Scientist, 

Taub Institute for the Aging Brain, 

Departments of Pathology and Cell 

Biology and Neurology, CU Medical 

Center, engaged in research misconduct 

in research supported by National 

Institute of Neurological Disorders and 

Stroke (NINDS), National Institutes of 

Health (NIH), grant R01 NS064433 and 

National Institute of Aging (NIA), NIH, 

grant R01 AG042317. 

ORI found that Respondent engaged 

in research misconduct by falsifying and 

fabricating data for specific protein 

expressions in human-induced neuronal 

(hiN) cells derived skin fibroblasts of 

Alzheimer’s disease patients and 

unaffected individuals in seventy-four 

(74) panels included in figures in the 

following two (2) publications and one 

(1) unpublished manuscript: 

• Cell 146:359–371, 2011 (hereafter 

referred to as ‘‘Cell 2011’’). 

• Nature 500:45–53, 2013 (hereafter 

referred to as ‘‘Nature 2013’’). 

• ‘‘Human induced neuron models of 

APOE4-associated Alzheimer’s disease 

display altered APP endocytosis and 

processing.’’ Unpublished manuscript. 

ORI found that Respondent engaged 

in research misconduct by knowingly 

and intentionally fabricating and 

falsifying research in seventy-four (74) 

mstockstill on DSK4VPTVN1PROD with NOTICES